| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant somatic hypermutations in thyroid lymphomas
|
Takakuwa, Tetsuya
|
|
2009
|
33 |
Supplement 1 |
p. 649-654
6 p.
|
artikel
|
| 2 |
Acute lymphoblastic leukemia following severe congenital neutropenia or de novo ALL?
|
Valera, Elvis Terci
|
|
2009
|
33 |
Supplement 1 |
p. e139-e142
nvt p.
|
artikel
|
| 3 |
Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes
|
Schanz, Julie
|
|
2009
|
33 |
Supplement 1 |
p. 1183-1188
6 p.
|
artikel
|
| 4 |
Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal
|
Breccia, M.
|
|
2009
|
33 |
Supplement 1 |
p. 391-394
4 p.
|
artikel
|
| 5 |
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial
|
Chevallier, Patrice
|
|
2009
|
33 |
Supplement 1 |
p. 1124-1126
3 p.
|
artikel
|
| 6 |
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
|
Kim, Hawk
|
|
2009
|
33 |
Supplement 1 |
p. 222-231
10 p.
|
artikel
|
| 7 |
A tumour stage-dependent evolution of drug resistant T cell lymphoma: Role of soluble mediators of tumour and host origin
|
Singh, Vivek
|
|
2009
|
33 |
Supplement 1 |
p. 700-709
10 p.
|
artikel
|
| 8 |
Author Index
|
|
|
2009
|
33 |
Supplement 1 |
p. S143-S150
8 p.
|
artikel
|
| 9 |
6 BMI-1 and AML1 point mutation in the pathogenesis of MDS
|
Kimura, A.
|
|
2009
|
33 |
Supplement 1 |
p. S2-S3
2 p.
|
artikel
|
| 10 |
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience
|
Zheng, Weiyan
|
|
2009
|
33 |
Supplement 1 |
p. 1615-1618
4 p.
|
artikel
|
| 11 |
Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia
|
Rogalinska, Malgorzata
|
|
2009
|
33 |
Supplement 1 |
p. 308-314
7 p.
|
artikel
|
| 12 |
C024 Association of NQO1 C609T polymorphism with chromosomes 5 and/or 7 abnormalities in patients with MDS/AML
|
Stavropoulou, C.
|
|
2009
|
33 |
Supplement 1 |
p. S45-S46
2 p.
|
artikel
|
| 13 |
C034 Biological factors of response to erythropoiesis-stimulating agents in low/int-1 grade MDS
|
Pawlikowska, P.
|
|
2009
|
33 |
Supplement 1 |
p. S51-S52
2 p.
|
artikel
|
| 14 |
C002 C-type lectin-like molecule-1 (CLL-1) and lineage infidelity marker expression as assessed by flow cytometry distinguishes normal and aberrant stem cells in myelodysplastic syndromes
|
Westers, T.
|
|
2009
|
33 |
Supplement 1 |
p. S31-S32
2 p.
|
artikel
|
| 15 |
C017 Expression of proteins p16INK4a, p53 and Bmi-1 in hematopoietic stem cells of patients with MDS. The role of cellular senescence
|
Constandinidou, I.
|
|
2009
|
33 |
Supplement 1 |
p. S41-S42
2 p.
|
artikel
|
| 16 |
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V
|
Ustun, Celalettin
|
|
2009
|
33 |
Supplement 1 |
p. 735-741
7 p.
|
artikel
|
| 17 |
c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D
|
Chen-Deutsch, Xiangwen
|
|
2009
|
33 |
Supplement 1 |
p. 1372-1378
7 p.
|
artikel
|
| 18 |
Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes
|
Wang, Rong
|
|
2009
|
33 |
Supplement 1 |
p. 1594-1598
5 p.
|
artikel
|
| 19 |
Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cells
|
Zhang, Yana
|
|
2009
|
33 |
Supplement 1 |
p. 166-169
4 p.
|
artikel
|
| 20 |
C033 Quantification of phosphoinositidephospholipase C (PI-PLC) beta 1 gene promoter methylation predicts the responsiveness to azacitidine in myelodysplastic syndromes
|
Follo, M.
|
|
2009
|
33 |
Supplement 1 |
p. S51-
1 p.
|
artikel
|
| 21 |
C027 The in vitro effect of SB-497115 (Eltrombopag) on megakaryopoiesis of patients with low/intermediate-1 IPSS myelodysplastic syndrome
|
Papadaki, H.
|
|
2009
|
33 |
Supplement 1 |
p. S47-S48
2 p.
|
artikel
|
| 22 |
C021 The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
|
Ohyashiki, J.
|
|
2009
|
33 |
Supplement 1 |
p. S44-
1 p.
|
artikel
|
| 23 |
C007 Validation of the WHO proposals for the classification of unclassifiable myelodysplastic syndromes
|
Germing, U.
|
|
2009
|
33 |
Supplement 1 |
p. S35-
1 p.
|
artikel
|
| 24 |
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
|
Forrest, Donna L.
|
|
2009
|
33 |
Supplement 1 |
p. 271-275
5 p.
|
artikel
|
| 25 |
Differential regulation of 11β-hydroxysteroid dehydrogenase-1 by dexamethasone in glucocorticoid-sensitive and -resistant childhood lymphoblastic leukemia
|
Sai, Shuji
|
|
2009
|
33 |
Supplement 1 |
p. 1696-1698
3 p.
|
artikel
|
| 26 |
14 Disruption of precise gene product expression in myelodysplasia
|
Loken, M.R.
|
|
2009
|
33 |
Supplement 1 |
p. S10-S11
2 p.
|
artikel
|
| 27 |
DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia
|
Batar, Bahadır
|
|
2009
|
33 |
Supplement 1 |
p. 759-763
5 p.
|
artikel
|
| 28 |
Dominant negative Tax double mutants as molecular inhibitors for w.t. Tax gene functions
|
Egbaria, Mahmoud
|
|
2009
|
33 |
Supplement 1 |
p. 974-979
6 p.
|
artikel
|
| 29 |
Editorial Board
|
|
|
2009
|
33 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 30 |
Editorial Board
|
|
|
2009
|
33 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 31 |
Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells
|
Akagi, Tadayuki
|
|
2009
|
33 |
Supplement 1 |
p. 991-996
6 p.
|
artikel
|
| 32 |
Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia
|
Chang, Hong
|
|
2009
|
33 |
Supplement 1 |
p. 259-262
4 p.
|
artikel
|
| 33 |
Good and bad IRF-1: Role in tumor suppression versus autoimmune disease
|
Liebermann, Dan A.
|
|
2009
|
33 |
Supplement 1 |
p. 1301-1302
2 p.
|
artikel
|
| 34 |
Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor
|
Imai, Norikazu
|
|
2009
|
33 |
Supplement 1 |
p. 1650-1657
8 p.
|
artikel
|
| 35 |
2-(1-Hydroxethyl)-4,8-dihydrobenzo[1,2-b:5,4-b′]dithiophene-4,8-dione (BTP-11) enhances the ATRA-induced differentiation in human leukemia HL-60 cells
|
Chen, Chun-Jen
|
|
2009
|
33 |
Supplement 1 |
p. 1664-1669
6 p.
|
artikel
|
| 36 |
Identification of annexin 1 as a PU.1 target gene in leukemia cells
|
Iseki, Yuko
|
|
2009
|
33 |
Supplement 1 |
p. 1658-1663
6 p.
|
artikel
|
| 37 |
Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts
|
Cermak, Jaroslav
|
|
2009
|
33 |
Supplement 1 |
p. 1469-1474
6 p.
|
artikel
|
| 38 |
Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity
|
Hoshi, Masato
|
|
2009
|
33 |
Supplement 1 |
p. 39-45
7 p.
|
artikel
|
| 39 |
Infant acute bilineal leukemia
|
Derwich, Katarzyna
|
|
2009
|
33 |
Supplement 1 |
p. 1005-1008
4 p.
|
artikel
|
| 40 |
Inhibition of all-trans retinoic acid-induced granulocytic differentiation of WEHI-3B D+ cells by forced expression of SCL (TAL1) and GATA-1
|
Ishiguro, Kimiko
|
|
2009
|
33 |
Supplement 1 |
p. 1249-1254
6 p.
|
artikel
|
| 41 |
Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia
|
Begleiter, Asher
|
|
2009
|
33 |
Supplement 1 |
p. 74-81
8 p.
|
artikel
|
| 42 |
29 In vitro basis for treatment with hypomethylating agents and HDAC inhibitors: Can epigenetic changes be used to monitor treatment?
|
Gore, S.D.
|
|
2009
|
33 |
Supplement 1 |
p. S24-
1 p.
|
artikel
|
| 43 |
JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)
|
Shami, Paul J.
|
|
2009
|
33 |
Supplement 1 |
p. 1525-1529
5 p.
|
artikel
|
| 44 |
Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1
|
Ye, Xueshi
|
|
2009
|
33 |
Supplement 1 |
p. 1114-1119
6 p.
|
artikel
|
| 45 |
Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells
|
Oveland, Eystein
|
|
2009
|
33 |
Supplement 1 |
p. 276-287
12 p.
|
artikel
|
| 46 |
Many are called MDS cell lines: One is chosen
|
Drexler, Hans G.
|
|
2009
|
33 |
Supplement 1 |
p. 1011-1016
6 p.
|
artikel
|
| 47 |
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST
|
Pitini, Vincenzo
|
|
2009
|
33 |
Supplement 1 |
p. e143-e144
nvt p.
|
artikel
|
| 48 |
NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells
|
Chen, Su
|
|
2009
|
33 |
Supplement 1 |
p. 1108-1113
6 p.
|
artikel
|
| 49 |
Non-hemic autoimmunity in CLL
|
Hamblin, Terry J.
|
|
2009
|
33 |
Supplement 1 |
p. 366-367
2 p.
|
artikel
|
| 50 |
Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines
|
Guo, Dongmei
|
|
2009
|
33 |
Supplement 1 |
p. 678-685
8 p.
|
artikel
|
| 51 |
Oligonucleotide array CGH studies in myeloproliferative neoplasms: Comparison with JAK2V617F mutational status and conventional chromosome analysis
|
Tefferi, Ayalew
|
|
2009
|
33 |
Supplement 1 |
p. 662-664
3 p.
|
artikel
|
| 52 |
P043 Aberrant immunophenotype of blasts in low and intermediate-1 risk myelodysplastic syndromes predicts response to growth factor treatment. A prospective clinical phase II study
|
Westers, T.
|
|
2009
|
33 |
Supplement 1 |
p. S83-
1 p.
|
artikel
|
| 53 |
P037 Apoptotic CD11bdimCD16pos neutrophil subpopulation represents a pitfall in pattern recognition of neutrophil differentiation by flow cytometry in myelodysplastic syndromes
|
Alhan, C.
|
|
2009
|
33 |
Supplement 1 |
p. S79-S80
2 p.
|
artikel
|
| 54 |
P125 A single cycle of azacitidine induces complete remission in a case of relapsed acute myeloid leukaemia (AML)
|
Stauder, R.
|
|
2009
|
33 |
Supplement 1 |
p. S132-
1 p.
|
artikel
|
| 55 |
P044 Bone marrow activated immune effectors and CD4 CD25highFoxp3 lymphocytes (T Reg) identify distinct subgroups of low and int-1 risk myelodysplastic patients
|
Alfinito, F.
|
|
2009
|
33 |
Supplement 1 |
p. S83-S84
2 p.
|
artikel
|
| 56 |
P104 Change in liver iron concentration (LIC), serum ferritin (SF) and labile plasma iron (LPI) over 1 year of deferasirox (Exjade®) therapy in a cohort of patients with MDS
|
Greenberg, P.L.
|
|
2009
|
33 |
Supplement 1 |
p. S120-
1 p.
|
artikel
|
| 57 |
P040 Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetic, and clinical data
|
Kern, W.
|
|
2009
|
33 |
Supplement 1 |
p. S81-S82
2 p.
|
artikel
|
| 58 |
P101 Deferiprone as a second line treatment in myelodysplastic syndromes. Case report
|
Iastrebner, M.
|
|
2009
|
33 |
Supplement 1 |
p. S118-
1 p.
|
artikel
|
| 59 |
P071 Derivative (1;7)(q10;p10) in two patients after autologous hematopoietic cell transplantation (AHCT)
|
Athanasiadou, A.
|
|
2009
|
33 |
Supplement 1 |
p. S100-
1 p.
|
artikel
|
| 60 |
P085 Efficacy of hypomethylating agents on rheumatologic manifestations in high risk myelodysplastic syndromes: first report of a potential indication for this emerging therapy
|
Reutenauer, S.
|
|
2009
|
33 |
Supplement 1 |
p. S107-S108
2 p.
|
artikel
|
| 61 |
P015 European LeukemiaNet registry programme for low/INT-1 IPSS score myelodysplastic syndromes
|
Bowen, D.
|
|
2009
|
33 |
Supplement 1 |
p. S66-S67
2 p.
|
artikel
|
| 62 |
Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma
|
Farag, Sherif S.
|
|
2009
|
33 |
Supplement 1 |
p. 1475-1480
6 p.
|
artikel
|
| 63 |
P013 Hellenic national registry of myelodysplastic and bone marrow failure syndromes (EAKMYS): report of 18 months of activity
|
Symeonidis, A.S.
|
|
2009
|
33 |
Supplement 1 |
p. S65-
1 p.
|
artikel
|
| 64 |
Phosphatase inhibition augments anti-CD22-mediated signaling and cytotoxicity in non-hodgkin's lymphoma cells
|
O’Donnell, Robert T.
|
|
2009
|
33 |
Supplement 1 |
p. 964-969
6 p.
|
artikel
|
| 65 |
Physical and functional interactions between hematopoietic cell-specific ETS transcription factors and homeodomain proteins
|
Yamada, Toshiyuki
|
|
2009
|
33 |
Supplement 1 |
p. 483-489
7 p.
|
artikel
|
| 66 |
P099 Influence of RBC transfusions on clinical outcomes among USA Medicare beneficiaries with newly diagnosed myelodysplastic syndromes
|
Goldberg, S.L.
|
|
2009
|
33 |
Supplement 1 |
p. S116-
1 p.
|
artikel
|
| 67 |
P110 Lenalidomide in low and int-1 risk MDS with del5q: efficacy and quality of life
|
Oliva, E.
|
|
2009
|
33 |
Supplement 1 |
p. S123-
1 p.
|
artikel
|
| 68 |
P115 Long-term transfusion independence in del(5q) patients despite discontinuation of lenalidomide
|
Giagounidis, A.
|
|
2009
|
33 |
Supplement 1 |
p. S126-S127
2 p.
|
artikel
|
| 69 |
P023 Lymphoid micromegakarycytes is a unfavourable prognostic factor in patients with primary myelodysplastic syndromes
|
Xiao, Z.
|
|
2009
|
33 |
Supplement 1 |
p. S71-
1 p.
|
artikel
|
| 70 |
P054 MicroRNA expression profiling of high and low risk MDS
|
Gaken, J.
|
|
2009
|
33 |
Supplement 1 |
p. S90-
1 p.
|
artikel
|
| 71 |
p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma
|
Sheth, Neil
|
|
2009
|
33 |
Supplement 1 |
p. 1357-1360
4 p.
|
artikel
|
| 72 |
Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma
|
Jamroziak, Krzysztof
|
|
2009
|
33 |
Supplement 1 |
p. 332-335
4 p.
|
artikel
|
| 73 |
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes
|
Fabiani, Emiliano
|
|
2009
|
33 |
Supplement 1 |
p. 1068-1071
4 p.
|
artikel
|
| 74 |
Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature
|
Paydas, Semra
|
|
2009
|
33 |
Supplement 1 |
p. 1627-1635
9 p.
|
artikel
|
| 75 |
P068 Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
|
Boehrer, S.
|
|
2009
|
33 |
Supplement 1 |
p. S98-S99
2 p.
|
artikel
|
| 76 |
PTEN deficiency is a common defect in juvenile myelomonocytic leukemia
|
Liu, Yunying Lucy
|
|
2009
|
33 |
Supplement 1 |
p. 671-677
7 p.
|
artikel
|
| 77 |
Renal intravascular large B-cell lymphoma with early diagnosis by renal biopsy: A case report and review of the literature
|
Niitsu, Nozomi
|
|
2009
|
33 |
Supplement 1 |
p. 728-730
3 p.
|
artikel
|
| 78 |
Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells
|
Akao, Yukihiro
|
|
2009
|
33 |
Supplement 1 |
p. 1530-1538
9 p.
|
artikel
|
| 79 |
Screening and cloning of multi-drug resistant genes in HL-60/MDR cells
|
Zheng, Gai-Huan
|
|
2009
|
33 |
Supplement 1 |
p. 1120-1123
4 p.
|
artikel
|
| 80 |
Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia
|
Poyer, Florent
|
|
2009
|
33 |
Supplement 1 |
p. 407-417
11 p.
|
artikel
|
| 81 |
sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia
|
Pehlivan, Melek
|
|
2009
|
33 |
Supplement 1 |
p. 1062-1067
6 p.
|
artikel
|
| 82 |
34 Should we use histone deacetylase inhibitors in the treatment of MDS?
|
Yang, A.S.
|
|
2009
|
33 |
Supplement 1 |
p. S26-
1 p.
|
artikel
|
| 83 |
Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia
|
Lee, Sung-Sook
|
|
2009
|
33 |
Supplement 1 |
p. 511-517
7 p.
|
artikel
|
| 84 |
Sorafenib (Nexavar®) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia
|
Safaian, N.N.
|
|
2009
|
33 |
Supplement 1 |
p. 348-350
3 p.
|
artikel
|
| 85 |
Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia
|
Véronèse, Lauren
|
|
2009
|
33 |
Supplement 1 |
p. 1623-1626
4 p.
|
artikel
|
| 86 |
Synergistic induction of gene expression during the differentiation into mature macrophage in human myeloblastic leukemia cells treated with TPA and KH1060
|
Shimizu, Takahisa
|
|
2009
|
33 |
Supplement 1 |
p. 803-809
7 p.
|
artikel
|
| 87 |
Targeted suppression of MCT-1 attenuates the malignant phenotype through a translational mechanism
|
Mazan-Mamczarz, Krystyna
|
|
2009
|
33 |
Supplement 1 |
p. 474-482
9 p.
|
artikel
|
| 88 |
Thalidomide treatment down-regulates SDF-1α and CXCR4 expression in multiple myeloma patients
|
Oliveira, Adriana Morgan
|
|
2009
|
33 |
Supplement 1 |
p. 970-973
4 p.
|
artikel
|
| 89 |
The ambiguous role of interferon regulatory factor-1 (IRF-1) immunoexpression in myelodysplastic syndrome
|
Pinheiro, Ronald Feitosa
|
|
2009
|
33 |
Supplement 1 |
p. 1308-1312
5 p.
|
artikel
|
| 90 |
The anti-apoptotic role of the unfolded protein response in Bcr-Abl-positive leukemia cells
|
Tanimura, Atsuko
|
|
2009
|
33 |
Supplement 1 |
p. 924-928
5 p.
|
artikel
|
| 91 |
The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells
|
Hirosawa, Megumi
|
|
2009
|
33 |
Supplement 1 |
p. 693-699
7 p.
|
artikel
|
| 92 |
The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: A prospective study
|
Truong, Francoise
|
|
2009
|
33 |
Supplement 1 |
p. 1039-1046
8 p.
|
artikel
|
| 93 |
Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells
|
Chen, Jing-Yi
|
|
2009
|
33 |
Supplement 1 |
p. 1520-1524
5 p.
|
artikel
|
| 94 |
Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome
|
Yamamoto, Katsuya
|
|
2009
|
33 |
Supplement 1 |
p. 377-383
7 p.
|
artikel
|
| 95 |
YI2 Diagnostic utility of a small four color panel for flow cytometric analysis in myelodysplastic syndromes
|
Reis-Alves, S.
|
|
2009
|
33 |
Supplement 1 |
p. S55-
1 p.
|
artikel
|
Tijdschrift beschrijving